Premium
Liver transplantation for HIV /hepatitis C virus co‐infected patients
Author(s) -
Takatsuki Mitsuhisa,
Soyama Akihiko,
Eguchi Susumu
Publication year - 2014
Publication title -
hepatology research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.123
H-Index - 75
eISSN - 1872-034X
pISSN - 1386-6346
DOI - 10.1111/hepr.12132
Subject(s) - immunosuppression , medicine , hepatocellular carcinoma , liver transplantation , hepatitis c virus , hepatitis c , human immunodeficiency virus (hiv) , immunology , transplantation , virology , virus
Since the introduction of antiretroviral therapy ( ART ) in the mid‐1990s, AIDS‐related death has been dramatically reduced, and hepatitis‐ C ‐virus ( HCV )‐related liver failure or hepatocellular carcinoma has currently become the leading cause of death in HIV / HCV co‐infected patients. Liver transplantation may be one of the treatments of choices in such cases, but the indications for transplantation, perioperative management including both HIV and HCV treatments, immunosuppression and the prevention/treatment of infectious complications are all still topics of debate. With the improved understanding of the viral behaviors of both HIV and HCV and the development of novel strategies, especially to avoid drug interactions between ART and immunosuppression, liver transplantation has become a realistic treatment for HIV / HCV co‐infected patients.